Thiogenesis Therapeutics, Corp. (TTIPF)
OTC: TTIPF · CIK 0001877778 · United States
Every official Thiogenesis Therapeutics, Corp. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open TTIPF filings
Thiogenesis Therapeutics, Corp. documents
- Thiogenesis Therapeutics, Corp. 10-K 2026TTIPF 10-K 2026: annual report for fiscal 2026
- Thiogenesis Therapeutics, Corp. 10-K 2025TTIPF 10-K 2025: annual report for fiscal 2025
- Thiogenesis Therapeutics, Corp. 10-K 2024TTIPF 10-K 2024: annual report for fiscal 2024
- Thiogenesis Therapeutics, Corp. 10-K 2023TTIPF 10-K 2023: annual report for fiscal 2023
- Thiogenesis Therapeutics, Corp. 10-K 2022TTIPF 10-K 2022: annual report for fiscal 2022
- Thiogenesis Therapeutics, Corp. 10-Q 2026TTIPF 10-Q 2026: quarterly report for fiscal 2026
- Thiogenesis Therapeutics, Corp. 10-Q 2025TTIPF 10-Q 2025: quarterly report for fiscal 2025
- Thiogenesis Therapeutics, Corp. 10-Q 2024TTIPF 10-Q 2024: quarterly report for fiscal 2024
- Thiogenesis Therapeutics, Corp. 10-Q 2023TTIPF 10-Q 2023: quarterly report for fiscal 2023
- Thiogenesis Therapeutics, Corp. 10-Q 2022TTIPF 10-Q 2022: quarterly report for fiscal 2022
- Thiogenesis Therapeutics, Corp. 8-K 2026TTIPF 8-K 2026: current report for fiscal 2026
- Thiogenesis Therapeutics, Corp. 8-K 2025TTIPF 8-K 2025: current report for fiscal 2025
- Thiogenesis Therapeutics, Corp. 8-K 2024TTIPF 8-K 2024: current report for fiscal 2024
- Thiogenesis Therapeutics, Corp. 8-K 2023TTIPF 8-K 2023: current report for fiscal 2023
- Thiogenesis Therapeutics, Corp. 8-K 2022TTIPF 8-K 2022: current report for fiscal 2022
- Thiogenesis Therapeutics, Corp. DEF 14A 2026TTIPF DEF 14A 2026: proxy statement for fiscal 2026
- Thiogenesis Therapeutics, Corp. DEF 14A 2025TTIPF DEF 14A 2025: proxy statement for fiscal 2025
- Thiogenesis Therapeutics, Corp. DEF 14A 2024TTIPF DEF 14A 2024: proxy statement for fiscal 2024
- Thiogenesis Therapeutics, Corp. DEF 14A 2023TTIPF DEF 14A 2023: proxy statement for fiscal 2023
- Thiogenesis Therapeutics, Corp. DEF 14A 2022TTIPF DEF 14A 2022: proxy statement for fiscal 2022
- Thiogenesis Therapeutics, Corp. Form 4 2026TTIPF Form 4 2026: insider trading filing for fiscal 2026
- Thiogenesis Therapeutics, Corp. Form 4 2025TTIPF Form 4 2025: insider trading filing for fiscal 2025
- Thiogenesis Therapeutics, Corp. Form 4 2024TTIPF Form 4 2024: insider trading filing for fiscal 2024
- Thiogenesis Therapeutics, Corp. Form 4 2023TTIPF Form 4 2023: insider trading filing for fiscal 2023
- Thiogenesis Therapeutics, Corp. Form 4 2022TTIPF Form 4 2022: insider trading filing for fiscal 2022
- Thiogenesis Therapeutics, Corp. S-1 2026TTIPF S-1 2026: registration statement for fiscal 2026
- Thiogenesis Therapeutics, Corp. S-1 2025TTIPF S-1 2025: registration statement for fiscal 2025
- Thiogenesis Therapeutics, Corp. S-1 2024TTIPF S-1 2024: registration statement for fiscal 2024
- Thiogenesis Therapeutics, Corp. S-1 2023TTIPF S-1 2023: registration statement for fiscal 2023
- Thiogenesis Therapeutics, Corp. S-1 2022TTIPF S-1 2022: registration statement for fiscal 2022
- Thiogenesis Therapeutics, Corp. 13F 2026TTIPF 13F 2026: institutional holdings for fiscal 2026
- Thiogenesis Therapeutics, Corp. 13F 2025TTIPF 13F 2025: institutional holdings for fiscal 2025
- Thiogenesis Therapeutics, Corp. 13F 2024TTIPF 13F 2024: institutional holdings for fiscal 2024
- Thiogenesis Therapeutics, Corp. 13F 2023TTIPF 13F 2023: institutional holdings for fiscal 2023
- Thiogenesis Therapeutics, Corp. 13F 2022TTIPF 13F 2022: institutional holdings for fiscal 2022
More companies